Table 1.
Description of the instruments used for the evaluation of all participants
| Instrument | Description | Domains/subscales | Score |
| MoCA29 | Paper and pencil cognitive screening test for evaluating mild cognitive impairment. | Attention and concentration, executive functions, memory, language, visuoconstructional skills, calculations, orientation. | Range: 0–30 Higher scores represent better cognitive performance. |
| 18-point CDT52 53 | The CDT is an assessment tool where participants are asked to draw a big circle, place the clock numbers and then indicate the time as ‘10 past 11’. An 18-point system will be used to score the test. | Visuospatial, executive function. | Range: 0–18 Scoring system with three main components: (A) assessment of circle integrity (two points); (B) number placement and sequencing (six points); and (C) placement and size of the hands (six points). Additionally, there are two points for representation of the clock’s centre and two points for general gestalt. |
| Brain on Track33 34 | Computerised and self-administered test that allows longitudinal monitoring of cognitive performance. | Attention, memory, executive functions, language, calculation, constructive ability, visuospatial processing. | Range: virtually unlimited (maximum number of correct answers in a fixed time). Higher scores represent better cognitive performance. Scores falling below an expected performance threshold for each age/education group represent a pattern of decline in individual performance. |
| HADS45 | Scale with 14 questions designed to assess anxiety and depression. Patients should answer considering the previous week. | Depression, anxiety. | Range (for each subscale): 0–21 Scores greater than or equal to 11 represent a case of anxiety or depression, as applicable. |
| PSQI44 | Quality of sleep index with 18 questions about the sleeping habits of the patients during the previous month. | Subjective sleep quality, sleep latency, duration of sleep, habitual sleep efficiency, sleep disorders, use of medications for sleep, daytime dysfunction. | Range: 0–21 Scores greater than 5 indicate poor sleep quality. |
| REM Sleep Behaviour Disorder Single‐Question Screen35 |
Single screening yes/no question about the classic dream-enactment behaviour in the REM behaviour disorder. | REM sleep behaviour disorder. | A positive answer suggests a presence of REM behaviour Disorder. |
| STOP-Bang questionnaire46 | Screening tool with eight yes or no questions related to the clinical features of sleep apnoea. | Obstructive sleep apnoea (OSA). | Range: 0–8 Each positive answer sum 1 to the final score, with higher scores representing more risk of OSA. Scores equal or greater than three indicate OSA. |
| 9-item PD screening questionnaire38 | Screening tool with nine yes or no questions | PD | Range: 0–9 Higher scores indicate higher likelihood of Parkinson’ Disease: unlikely if scores are 0–1; possible if scores are 2–4; and probable if scores are ≥5. |
| Timed “Up and Go” test40 | Test to evaluate the ability of patients to perform sequential locomotor tasks that incorporate walking and turning. | Mobility, gait and balance (ability to stand up from the chair, walking characteristics, presence of ‘freezing’ walking, posture). |
5-point Likert scale (normal, discreet, mild, moderate and severe) and global gait diagnosis: normal or altered, with parkinsonism and/or osteoarticular and/or vascular and/or others features. |
CDT, Clock Drawing Test; HADS, Hospital Anxiety and Depression Scale; MoCA, Montreal Cognitive Assessment; PD, Parkinson’s disease; PSQI, Pittsburgh Sleep Quality Index; REM, rapid eye movement.